ANDERSON DAVID WESLEY
No ORCID on file
· 26 papers in corpus
· active 2001-2002
Frequent coauthors
- BHAGWAT SHRIPAD S 26
- DOUBLEDAY MARY 26
- GAYO-FUNG LEAH M 26
- JALLURI RAVI KUMAR 26
- KOIS ADAM 26
- KHAMMUNGKHUNE SAK 26
- MCKIE JEFFREY A 26
- SHEVLIN GRAZIELLA I 26
- STEIN BERND M 26
- SUTHERLAND MAY S 13
2002
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same:wherein R1, R2, R3, n and p are as defined here. Methods are…
2002
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same:wherein R1, R2, R3, n and p are as defined here. Methods are…
2002
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same:wherein R1, R2, R3, n and p are as defined here. Methods are…
2002
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same:wherein R1, R2, R3, n and p are as defined here. Methods are…
2002
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same:wherein R1, R2, R3, n and p are as defined here. Methods are…
2002
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same:wherein R1, R2, R3, n and p are as defined here. Methods are…
2002
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same:wherein R1, R2, R3, n and p are as defined here. Methods are…
2002
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same:wherein R1, R2, R3, n and p are as defined here. Methods are…
2002
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same:wherein R1, R2, R3, n and p are as defined here. Methods are…
2002
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same:wherein R1, R2, R3, n and p are as defined here. Methods are…
2002
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same:wherein R1, R2, R3, n and p are as defined here. Methods are…
2002
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same:wherein R1, R2, R3, n and p are as defined here. Methods are…
2002
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same:wherein R1, R2, R3, n and p are as defined here. Methods are…
2001
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same:wherein R1, R2, R3, n and p are as defined here. Methods …
2001
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same:wherein R1, R2, R3, n and p are as defined here. Methods …
2001
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same:wherein R1, R2, R3, n and p are as defined here. Methods …
2001
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same:wherein R1, R2, R3, n and p are as defined here. Methods …
2001
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same:wherein R1, R2, R3, n and p are as defined here. Methods …
2001
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same:wherein R1, R2, R3, n and p are as defined here. Methods …
2001
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same:wherein R1, R2, R3, n and p are as defined here. Methods …
2001
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same:wherein R1, R2, R3, n and p are as defined here. Methods …
2001
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same:wherein R1, R2, R3, n and p are as defined here. Methods …
2001
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same:wherein R1, R2, R3, n and p are as defined here. Methods …
2001
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same:wherein R1, R2, R3, n and p are as defined here. Methods …
2001
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same:wherein R1, R2, R3, n and p are as defined here. Methods …